223 related articles for article (PubMed ID: 32733962)
1. The Platelet microRNA Profile of Kawasaki Disease: Identification of Novel Diagnostic Biomarkers.
Ning Q; Chen L; Song S; Zhang H; Xu K; Liu J; Zhou Y; Zang C; Li G; Chen F; Jia J; Ding G; Huang M
Biomed Res Int; 2020; 2020():9061568. PubMed ID: 32733962
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood.
Jone PN; Korst A; Karimpour-Fard A; Thomas T; Dominguez SR; Heizer H; Anderson MS; Glode MP; Sucharov CC; Miyamoto SD
J Mol Cell Cardiol; 2020 Sep; 146():12-18. PubMed ID: 32634388
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Significance of miR-937 in Peripheral Blood Mononuclear Cells of Kawasaki Disease.
Wang Z; Zhou J; Dong N; Li W
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710429
[TBL] [Abstract][Full Text] [Related]
4. Serum exosomal microRNA let-7i-3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm.
Wang YF; Lian XL; Zhong JY; Su SX; Xu YF; Xie XF; Wang ZP; Li W; Zhang L; Che D; Yu L; Huang P; Jia HL; Gu XQ
IUBMB Life; 2019 Jul; 71(7):891-900. PubMed ID: 30724444
[TBL] [Abstract][Full Text] [Related]
5. Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease.
Jia HL; Liu CW; Zhang L; Xu WJ; Gao XJ; Bai J; Xu YF; Xu MG; Zhang G
Sci Rep; 2017 Mar; 7():44706. PubMed ID: 28317854
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
Rong X; Jia L; Hong L; Pan L; Xue X; Zhang C; Lu J; Jin Z; Qiu H; Wu R; Chu M
J Cardiovasc Transl Res; 2017 Feb; 10(1):1-8. PubMed ID: 27981487
[TBL] [Abstract][Full Text] [Related]
7. A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs.
Li Z; Jiang J; Tian L; Li X; Chen J; Li S; Li C; Yang Z
PLoS One; 2017; 12(5):e0175407. PubMed ID: 28467514
[TBL] [Abstract][Full Text] [Related]
8. A study of cardiovascular miRNA biomarkers for Kawasaki disease.
Rowley AH; Pink AJ; Reindel R; Innocentini N; Baker SC; Shulman ST; Kim KY
Pediatr Infect Dis J; 2014 Dec; 33(12):1296-9. PubMed ID: 25037038
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Value of Serum MiR-1 in Patients with Acute Kawasaki Disease.
Yan J; Wang H; Gao L
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307166
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum level of microRNA (miRNA)-200c and miRNA-371-5p in children with Kawasaki disease.
Yun KW; Lee JY; Yun SW; Lim IS; Choi ES
Pediatr Cardiol; 2014 Jun; 35(5):745-52. PubMed ID: 24259014
[TBL] [Abstract][Full Text] [Related]
11. Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance.
Zhang R; Wu L; Zhang HJ; Gao XJ; Pan XT; Wang XR; Ye H; Liu GH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12757-12762. PubMed ID: 33378024
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of differential expression of miR-455-5p in plasma of children with Kawasaki disease.
Jiang J; Li Z; Li X; Li S; Yang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):673-677. PubMed ID: 32879124
[TBL] [Abstract][Full Text] [Related]
13. Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.
Weng KP; Cheng CF; Chien KJ; Ger LP; Huang SH; Tsai KW
Curr Issues Mol Biol; 2021 Jun; 43(2):485-500. PubMed ID: 34202375
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of miR-145 in children with Kawasaki disease.
Shimizu C; Kim J; Stepanowsky P; Trinh C; Lau HD; Akers JC; Chen C; Kanegaye JT; Tremoulet A; Ohno-Machado L; Burns JC
PLoS One; 2013; 8(3):e58159. PubMed ID: 23483985
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed microRNAs in acute Kawasaki disease.
Chen Y; Ding YY; Ren Y; Cao L; Xu QQ; Sun L; Xu MG; Lv HT
Mol Med Rep; 2018 Jan; 17(1):932-938. PubMed ID: 29115644
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-200c and miR-371-5p as the Useful Diagnostic Biomarkers and Therapeutic Targets in Kawasaki Disease.
Zhang W; Wang Y; Zeng Y; Hu L; Zou G
Biomed Res Int; 2017; 2017():8257862. PubMed ID: 28656149
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNAs characterising patients with immune thrombocytopenic purpura.
Zuo B; Zhai J; You L; Zhao Y; Yang J; Weng Z; Dai L; Wu Q; Ruan C; He Y
Thromb Haemost; 2017 Jun; 117(7):1420-1431. PubMed ID: 28424819
[TBL] [Abstract][Full Text] [Related]
18. miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease.
He M; Chen Z; Martin M; Zhang J; Sangwung P; Woo B; Tremoulet AH; Shimizu C; Jain MK; Burns JC; Shyy JY
Circ Res; 2017 Jan; 120(2):354-365. PubMed ID: 27923814
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
20. Changes in and significance of platelet function and parameters in Kawasaki disease.
Zheng X; Wu W; Zhang Y; Wu G
Sci Rep; 2019 Nov; 9(1):17641. PubMed ID: 31776411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
